CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel; Maja Ølholm Vase; Kristina Lystlund Lauridsen; Marie Beck Enemark; Michael Boe Møller; Court Pedersen; Gitte Pedersen; Stephen Hamilton-Dutoit; Niels Obel; Carsten Schade Larsen; Francesco d'Amore; Maja Ludvigsen

doi:10.1080/10428194.2021.2023741

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, Maja Ludvigsen

Department of Infectious Diseases

3 Citations (Scopus)

Original language	English
Journal	Leukemia and Lymphoma
Volume	63
Issue number	6
Pages (from-to)	1479-1483
Number of pages	5
ISSN	1042-8194
DOIs	https://doi.org/10.1080/10428194.2021.2023741
Publication status	Published - Jun 2022

Keywords

ADP-ribosyl Cyclase 1
HIV
HIV Infections/complications
Humans
Lymphoma/complications

Access to Document

10.1080/10428194.2021.2023741

Cite this

Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d'Amore, F., & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia and Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

Hybel, TE, Vase, MØ, Lauridsen, KL, Enemark, MB, Møller, MB, Pedersen, C, Pedersen, G, Hamilton-Dutoit, S, Obel, N, Schade Larsen, C, d'Amore, F & Ludvigsen, M 2022, 'CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus', Leukemia and Lymphoma, vol. 63, no. 6, pp. 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

@article{d1806891a9c74f9bace8b9a922fa2fac,

title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",

keywords = "ADP-ribosyl Cyclase 1, HIV, HIV Infections/complications, Humans, Lymphoma/complications",

author = "Hybel, \{Trine Engelbrecht\} and Vase, \{Maja {\O}lholm\} and Lauridsen, \{Kristina Lystlund\} and Enemark, \{Marie Beck\} and M{\o}ller, \{Michael Boe\} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and \{Schade Larsen\}, Carsten and Francesco d'Amore and Maja Ludvigsen",

year = "2022",

month = jun,

doi = "10.1080/10428194.2021.2023741",

language = "English",

volume = "63",

pages = "1479--1483",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

AU - Hybel, Trine Engelbrecht

AU - Vase, Maja Ølholm

AU - Lauridsen, Kristina Lystlund

AU - Enemark, Marie Beck

AU - Møller, Michael Boe

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Hamilton-Dutoit, Stephen

AU - Obel, Niels

AU - Schade Larsen, Carsten

AU - d'Amore, Francesco

AU - Ludvigsen, Maja

PY - 2022/6

Y1 - 2022/6

KW - ADP-ribosyl Cyclase 1

KW - HIV

KW - HIV Infections/complications

KW - Humans

KW - Lymphoma/complications

UR - https://www.scopus.com/pages/publications/85122825283

U2 - 10.1080/10428194.2021.2023741

DO - 10.1080/10428194.2021.2023741

M3 - Letter

C2 - 35019824

SN - 1042-8194

VL - 63

SP - 1479

EP - 1483

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Keywords

Access to Document

Other files and links

Cite this